| abstract |
The present invention provides a dual target drug carrier comprising a first target molecule and a second target molecule, wherein the target molecule comprises a peptide, an antibody or a protein. The target molecule of the present invention can bind to a specific receptor, specific protein or glycoprotein or the like to recognize a specific tumor cell, tissue or organ. The dual target molecule of the present invention can be further conjugated with an imaging substance, a radiotherapy substance (radiopharmaceutical, an isotope or a chemotherapeutic drug) or a nanoparticle to form a conjugate. |